168 related articles for article (PubMed ID: 23474960)
21. Background parenchymal enhancement at breast MR imaging and breast cancer risk.
King V; Brooks JD; Bernstein JL; Reiner AS; Pike MC; Morris EA
Radiology; 2011 Jul; 260(1):50-60. PubMed ID: 21493794
[TBL] [Abstract][Full Text] [Related]
22. Effects of gadobutrol on background parenchymal enhancement and differential diagnosis between benign and malignant lesions in dynamic magnetic resonance imaging of the breast.
Tozaki M; Yabuuchi H; Goto M; Sasaki M; Kubota K; Nakahara H
Breast Cancer; 2021 Jul; 28(4):927-936. PubMed ID: 33625722
[TBL] [Abstract][Full Text] [Related]
23. Three-Dimensional Quantitative Validation of Breast Magnetic Resonance Imaging Background Parenchymal Enhancement Assessments.
Ha R; Mema E; Guo X; Mango V; Desperito E; Ha J; Wynn R; Zhao B
Curr Probl Diagn Radiol; 2016; 45(5):297-303. PubMed ID: 27039221
[TBL] [Abstract][Full Text] [Related]
24. Should breast MRI be performed with adjustment for the phase in patients' menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients' menstrual cycle.
Uematsu T; Kasami M; Watanabe J
Eur J Radiol; 2012 Jul; 81(7):1539-42. PubMed ID: 21592704
[TBL] [Abstract][Full Text] [Related]
25. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
[TBL] [Abstract][Full Text] [Related]
26. Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging.
Kawamura A; Satake H; Ishigaki S; Ikeda M; Kimura R; Shimamoto K; Naganawa S
Nagoya J Med Sci; 2015 Aug; 77(3):425-37. PubMed ID: 26412889
[TBL] [Abstract][Full Text] [Related]
27. Metabolic Activity of Normal Glandular Tissue on
An YS; Jung Y; Kim JY; Han S; Kang DK; Park SY; Kim TH
J Breast Cancer; 2017 Dec; 20(4):386-392. PubMed ID: 29285044
[TBL] [Abstract][Full Text] [Related]
28. Normal breast parenchyma: contrast enhancement kinetics at dynamic MR mammography--influence of anthropometric measures and menopausal status.
Hegenscheid K; Schmidt CO; Seipel R; Laqua R; Ohlinger R; Kühn JP; Hosten N; Puls R
Radiology; 2013 Jan; 266(1):72-80. PubMed ID: 23023963
[TBL] [Abstract][Full Text] [Related]
29. Effect of Background Parenchymal Enhancement on Pre-Operative Breast Magnetic Resonance Imaging: How It Affects Interpretation and the Role of Second-Look Ultrasound in Patient Management.
Kim SY; Lee HS; Kim EK; Kim MJ; Moon HJ; Yoon JH
Ultrasound Med Biol; 2016 Dec; 42(12):2766-2774. PubMed ID: 27658753
[TBL] [Abstract][Full Text] [Related]
30. Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?
Dontchos BN; Rahbar H; Partridge SC; Korde LA; Lam DL; Scheel JR; Peacock S; Lehman CD
Radiology; 2015 Aug; 276(2):371-80. PubMed ID: 25965809
[TBL] [Abstract][Full Text] [Related]
31. The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis.
Thompson CM; Mallawaarachchi I; Dwivedi DK; Ayyappan AP; Shokar NK; Lakshmanaswamy R; Dwivedi AK
Radiology; 2019 Sep; 292(3):552-561. PubMed ID: 31237494
[TBL] [Abstract][Full Text] [Related]
32. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
33. Relationship Between Breast Ultrasound Background Echotexture and Magnetic Resonance Imaging Background Parenchymal Enhancement and the Effect of Hormonal Status Thereon.
Kim SJ; Jung HK; Han BK; Lee JH; Oh KS; Lee JS; Lee Y
Ultrasound Q; 2020 Jun; 36(2):179-191. PubMed ID: 32511210
[TBL] [Abstract][Full Text] [Related]
34. Comparison of contrast enhancement and diffusion-weighted magnetic resonance imaging in healthy and cancerous breast tissue.
Cho GY; Moy L; Kim SG; Klautau Leite AP; Baete SH; Babb JS; Sodickson DK; Sigmund EE
Eur J Radiol; 2015 Oct; 84(10):1888-93. PubMed ID: 26220915
[TBL] [Abstract][Full Text] [Related]
35. Background parenchymal enhancement: is it just an innocent effect of estrogen on the breast?
Arslan G; Çelik L; Çubuk R; Çelik L; Atasoy MM
Diagn Interv Radiol; 2017; 23(6):414-419. PubMed ID: 29097344
[TBL] [Abstract][Full Text] [Related]
36. Comparison of background parenchymal enhancement (BPE) on contrast-enhanced cone-beam breast CT (CE-CBBCT) and breast MRI.
Ma Y; Liu A; Zhang Y; Zhu Y; Wang Y; Zhao M; Liang Z; Qu Z; Yin L; Lu H; Ye Z
Eur Radiol; 2022 Aug; 32(8):5773-5782. PubMed ID: 35320411
[TBL] [Abstract][Full Text] [Related]
37. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
38. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
Gokalp G; Topal U; Yildirim N; Tolunay S
Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women.
Clendenen TV; Kim S; Moy L; Wan L; Rusinek H; Stanczyk FZ; Pike MC; Zeleniuch-Jacquotte A
Magn Reson Imaging; 2013 Jan; 31(1):1-9. PubMed ID: 22898693
[TBL] [Abstract][Full Text] [Related]
40. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
